19-35049978-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001384133.1(HPN):c.160+462A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.746 in 151,788 control chromosomes in the GnomAD database, including 42,407 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.75   (  42407   hom.,  cov: 29) 
Consequence
 HPN
NM_001384133.1 intron
NM_001384133.1 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -3.98  
Publications
12 publications found 
Genes affected
 HPN  (HGNC:5155):  (hepsin) This gene encodes a type II transmembrane serine protease that may be involved in diverse cellular functions, including blood coagulation and the maintenance of cell morphology. Expression of the encoded protein is associated with the growth and progression of cancers, particularly prostate cancer. The protein is cleaved into a catalytic serine protease chain and a non-catalytic scavenger receptor cysteine-rich chain, which associate via a single disulfide bond. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.831  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| HPN | NM_001384133.1 | c.160+462A>G | intron_variant | Intron 4 of 12 | ENST00000672452.2 | NP_001371062.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.746  AC: 113218AN: 151672Hom.:  42380  Cov.: 29 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
113218
AN: 
151672
Hom.: 
Cov.: 
29
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.746  AC: 113293AN: 151788Hom.:  42407  Cov.: 29 AF XY:  0.748  AC XY: 55486AN XY: 74158 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
113293
AN: 
151788
Hom.: 
Cov.: 
29
 AF XY: 
AC XY: 
55486
AN XY: 
74158
show subpopulations 
African (AFR) 
 AF: 
AC: 
29071
AN: 
41322
American (AMR) 
 AF: 
AC: 
12583
AN: 
15252
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2880
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
4396
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
3444
AN: 
4806
European-Finnish (FIN) 
 AF: 
AC: 
7911
AN: 
10518
Middle Eastern (MID) 
 AF: 
AC: 
245
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
50351
AN: 
67946
Other (OTH) 
 AF: 
AC: 
1642
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 1454 
 2908 
 4362 
 5816 
 7270 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 854 
 1708 
 2562 
 3416 
 4270 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2655
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.